Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad,

Blood Loss During Cesarean Section. Comparing Two Techniques of Blunt Expansion of Uterine Incision: Transversal vs. Cephalad-caudad. A Randomized, Controlled Trial.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01892215

Enrollment

839

Registered

2013-07-04

Start date

2012-10-31

Completion date

2013-06-30

Last updated

2017-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blunt Expansion of the Uterine Incision

Keywords

Uterine incision., Blunt transversal expansion., Blunt cephalad-caudad expansion.

Brief summary

Obstetrical blood loss is an important reason of maternal morbidity and mortality. Because of the increase in the rate of cesarean section, any procedure that could help reduce blood loss during cesarean section should be investigated. The purpose of this study was to compare 2 methods of blunt expansion of the uterine incision at the time of cesarean delivery: transversal vs. cephalad-caudad.

Interventions

PROCEDURECephalad-caudad expansion

Blunt expansion of the uterine incision by the physician separating the fingers in a cephalad-caudad direction.

PROCEDURETransversal expansion

Blunt expansion of the uterine incision by the physician separating the fingers in a transversal direction.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Singleton pregnancies * Gestational age: 34 weeks or more * Delivery by cesarean section * Presurgical hemoglobin \> 10.5 g/dL

Exclusion criteria

* Two or more previous cesarean sections * History of uterine rupture in a previous pregnancy * History of myomectomy * History of abdominal trauma with an uterine lesion * Blood dyscrasia * Multiple pregnancy * Placenta previa * Abruptio placenta * Stillbirth * Sharp uterine expansion

Design outcomes

Primary

Measure	Time frame	Description
Blood loss (hemoglobin level)	72 hours	Difference in hemoglobin level between 24 hours pre-surgery and the hemoglobin level before leaving the hospital.

Secondary

Measure	Time frame	Description
Surgical complications	72 hours	Number of cases of surgical complications (hematomas, unintended extension of the uterine incision, need for transfusion) between the two techniques.
Unintented extension of uterine incision	72 hours	Number of cases of unintended extension of the uterine incision during surgery between the two techniques.
Hematoma formation	72 hours	Number of cases of hematoma formation during or after between the two techniques.
Need for transfusion	72 hours	Number of cases that required a blood transfusion between the two techniques.

Countries

Panama

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026